Gut: Portal of entry of fungi in the immunocompromised hosts

Mikologia Lekarska

Volumn 11, Issue 2, 2004, Pages 105-107

  Samonis, George ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Candida; Gut; Immunodefects; Invasive fungal infections; Yeast

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; CYTOTOXIC AGENT; FLUCONAZOLE;

ANTIBIOTIC THERAPY; CANDIDA; CANDIDIASIS; DISEASE PREDISPOSITION; FUNGAL STRAIN; FUNGEMIA; FUNGUS; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTESTINE; INTESTINE MOTILITY; INTESTINE MUCOSA; MORBIDITY; MORTALITY; MYCOSIS; REVIEW; RISK FACTOR; STOMACH PH;

CANDIDA; FUNGI;

EID: 9144238401     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Kontoyiannis D.P., Mantadakis E., Samonis G.: Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J. Hosp. Infect., 2003, 53, 243-258.
2. Edmond M.B., Wallace S.E., McClish D.K. et al.: Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis., 1999, 29, 239-244.
3. Martino P., Girmenia C., Venditti M. et al.: Candida colonization and systemic infection in neutropenic patients. Cancer, 1989, 64, 2030-2034.
4. Saiman L., Ludington E., Dawson J.D., et al.: Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr. Infect. Dis. J., 2001, 20, 1119-1124.
5. Nucci M., Anaissie E.: Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis., 2001, 33, 1959-1967.
6. Krause W., Matheis H., Wulf K.: Fungaemia and funguria after oral administration of Candida albicans. Lancet, 1969, 1, 598-599.
7. Samonis G., Anaissie E.J., Rosenbaum B. et al.: A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice. Infect. Immun., 1990, 58, 1514-1517.
8. Pappu-Katikaneni L.D., Rao K.P., Banister E.: Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses, 1990, 33, 20-23.
9. Samonis G., Gikas A., Anaissie E.J. et al.: Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob. Agents. Chemother., 1993, 37, 51-53.
10. Trenschel R., Peceny R., Runde V., et al.: Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant., 2000, 26, 993-997.
11. Bow E.J., Loewen R., Cheang M.S., et al.: Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin. Infect. Dis., 1995, 21, 361-369.
12. Garbino J., Lew D.P., Romand J.A., et al.: Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med., 2002, 28, 1708-1717.
13. Nguyen M.H., Peacock J.E. Jr, Morris A.J. et al.: The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med., 1996, 100, 617-623.
14. Baran J. Jr, Muckatira B., Khatib R.: Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand. J. Infect. Dis., 2001, 33, 137-139.